Mnemo is using its EnfiniT platform, an integrated drug discovery engine that combines:
- A proprietary combination of epigenetics tools assembled into powerful T cell engineering technologies
- A revolutionary target ID engine that sources newly-identified junctions between exons and transposable elements (JETs)
- Best-in-class manufacturing
Mnemo will transform the body’s immune response to overcome currently incurable diseases.
Our path is created by decades of breakthrough research from Institut Curie and Memorial Sloan Kettering. Mnemo is built by a transatlantic team of scientists and biotech leaders united in a quest to create the most powerful immune therapies to deliver accessible cures for all patients in need.
Learn more about the Mnemo story and our scientific publications.
We are co-located in Paris and New York and affiliated with leading researchers from Institut Curie and Memorial Sloan Kettering. Our mission is to change the future of cell therapy for all patients. Our sense of urgency and high-energy create an exciting, collaborative and cohesive work environment focused on achieving scientific and medical breakthroughs and being the best at what we do.
Join our Team.
Mnemo is driven to create powerful immune therapies that will help overcome diseases and turn our vision of accessible cures into reality. Our commitment to research excellence is producing unprecedented results. We believe that our vision can only be achieved through a team culture that is inclusive, diverse and resilient.